Kevin J. Wiersma

All filings by Kevin J. Wiersma on record concern Medtox Scientific Inc. In total, 50 filings cover trades dated from 3 January 2006 to 31 July 2012.

Sales make up the whole of the open-market record (4 sales, €538k). Besides market trades, the filings include 33 share grants and 6 option exercises.

The newest entry dates from 1 August 2012: a transaction of €91k, in Medtox Scientific Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.